InsidersTradesSigma
Track the Santhera Pharmaceuticals Holding AG stock price and the full management transaction log of the company, a listed issuer based in Switzerland. Shares are quoted on the CH market, under the oversight of SIX SER. Operating in the Health Care sector, Santhera Pharmaceuticals Holding AG has logged 3 insider filings. Market capitalisation: €214.2m. The latest transaction was reported on 25 June 2024 (Sale). Every trade is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€313,722
2 ops.
Buy Volume
€9,423
1 ops.
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,906 of 28,717 companies
12.0
score / 100
Value11
Quality13
FCF yld-16%
Earn yld-23%
EV/EBITDA·
ROE·
Gross mgn20%
Net mgn-64%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 June 2024
Declarations3 total
●
Anonymous (Executive member of the board of directors / member of senior management)
1,057 shares@ CHF 8.54872.9% of flowISIN CH1276028821SIX:T1O6P00087
●
Anonymous (Executive member of the board of directors / member of senior management)
30,228 shares@ CHF 9.180.17% mcap94.0% of flowISIN CH1276028821SIX:T1O1I00026
●
Anonymous (Executive member of the board of directors / member of senior management)
2,000 shares@ CHF 9.200.011% mcap6.0% of flowISIN CH1276028821SIX:T1N7500025
3 of 3 declarations
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG is a Swiss biopharmaceutical company focused on developing treatments for rare diseases. It primarily targets muscular and neurological disorders.